Pediatric Ophthalmology and Strabismus. Screening examinations of premature infants for retinopathy of prematurity. Pediatrics.

2006;117:572. Erratum Pediatrics 2006;118:1324.

2. Wilkinson AR, Haines L, Head K, et al. UK retinopathy of prematurity guidelines. Early Hum Dev. 2008;84:71.

3. Jefferies AL, Canadian Pediatric Society; Fetus and Newborn

Committee. Retinopathy of prematurity: recommendations for

screening. Paediatr Child Health. 2010;15:667.

4. An International Committee for the Classification of Retinopathy

of Prematurity. The international classification of retinopathy of

prematurity revisited. Arch Ophthalmol. 2005;123:991.

5. Silva RA, Murakami Y, Lad EM, et al. Stanford University network for diagnosis of retinopathy of prematurity (SUNDROP): 36

month experience with telemedicine screening. Ophthalmic Surg

Lasers Imaging. 2011;42:12.

6. Kivlin JD, Biglan AW, Gordon RA, et al. For Cryotherapy for

Retinopathy of Prematurity Group. Early retinal vessel development and iris vessel dilatation as factors in retinopathy of prematurity. Arch Ophthalmol. 1996;114:150.

7. Marcus I, Salchow DJ, Stoessel KM, et al. An ROP screening

dilemma: hereditary cataracts developing in a premature infant

after birth. J Pediatr Ophthalmol Strabismus. 2012;14:49;e1.

8. Simpson JL, Melia M, Yang MB. A report by the American

Academy of Ophthalmology. Current role of cryotherapy in retinopathy of prematurity. Ophthalmology. 2012;119:873.

9. Houston SK, Wykoff CC, Berrocal AM, et al. Laser treatment for

retinopathy of prematurity. Lasers Med Sci. 2011 Dec 2. [Epub

ahead of print].

10. Early Treatment for Retinopathy of Prematurity Cooperative

Group. Revised indications for the treatment of retinopathy of

prematurity: results of the Early Treatment for retinopathy of

Prematurity randomized trial. Arch Ophthalmol. 2003;121:1684.

11. Early Treatment for Retinopathy of Prematurity Cooperative Group.

Final visual acuity results in the Early Treatment for Retinopathy of

Prematurity Study. Arch Ophthalmol. 2010;128: 663.

12. Hubbard GB. Surgical management of retinopathy of prematurity. Curr Opin Ophthalmol. 2008;19:384.

13. Mintz-Hittner HA, Kennedy KA, Chuang AZ, et al. Efficacy of

intravitreal bevacizumab for stage 3+ retinopathy of prematurity.

N Engl J Med. 2011;364:603.

14. Darlow BA, Ellis AL, Gilbert CE, et al. Are we there yet?

Bevacizumab therapy for retinopathy of prematurity. Arch Dis

Child Fetal Neonatal Ed. 2011 Dec 30. [Epub ahead of print].

15. Tolentino M. Systemic and ocular safety of intravitreal anti-VEGF therapies for ocular neovascular disease. Surv Ophthalmol. 2011;56:95.

16. Spandau U, Tomic Z, Ewald U, et al. Time to consider a new

treatment protocol for aggressive posterior retinopathy of prematurity? Acta Ophthalmol. 2012 Jan 23. [Epub ahead of print].

17. Lim LS, Mitchell P, Wong TY. Bevacizumab for retinopathy of

prematurity: letter. N Engl J Med. 2011;364:2359.

18. Day S, Menke AM, Abbott RL. Retinopathy of prematurity malpractice claims: the Ophthalmic Mutual Insurance Company

experience. Arch Ophthalmol. 2009;127:794.

19. Davitt BV, Quinn GE, Wallace DK, et al. Early Treatment for

Retinopathy of Prematurity Cooperative Group. Astigmatism progression in the early treatment for retinopathy study to 6 years of

age. Ophthalmology. 2011;118:2326.